Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars... Read more.
Biosimilars & Beyond: Ravi Sharma on Access, Trust & the Future of Care
We sat down with Ravi Sharma, Chief Group Pharmacy Officer at Burjeel Holdings, for a compelling conversation on the evolving role of biosimilars in modern healthcare.... Read more.
Ardelyx Announces Changes to the Executive Leadership Team
Ardelyx, a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet... Read more.
Gulf Medical University Empowers 100 High School Students Through Real-World Medical Exposure
Gulf Medical University (GMU), proudly announces the successful certification of 100 high school students from its flagship preparatory program, Aspire to Become... Read more.
MoHAP: The UAE is a regional leader in fighting hepatitis
34 years of commitment: a sustained journey against disease ย The Ministry of Health and Preventionย (MoHAP) has reaffirmed that fighting viral hepatitisย isย a... Read more.
Malnutrition rates reach alarming levels in Gaza, WHO warns
Malnutrition is on a dangerous trajectory in the Gaza Strip, marked by a spike in deaths in July. Of 74 malnutrition-related deaths in 2025, 63 occurred in July... Read more.
Protecting Childrenโs Health: Vaccine Hesitancy, Travel Risks & AMR | Dr. Huda ALDanhani at SEHA 2025
The 19th Seha International Pediatric Conference has been described as more than just a conferenceโit’s a “grand celebration” of knowledge, engagement,... Read more.
GSK Partners with Hengrui Pharma to Advance COPD and Oncology Drug Pipeline
GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to the... Read more.
Pfizer Completes Licensing Agreement with 3SBio
Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizerโs innovative Oncology portfolio Pfizer Inc. (NYSE: PFE)... Read more.
Monash University Researcher Recognised for Excellence in Stroke Prevention Research
Dr Lachlan Dalli from the Stroke and Ageing Research Group at the School of Clinical Sciences at Monash Health has been honoured with the prestigious 2025 Bethlehem... Read more.